PMC:7172841 / 4022-4385 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T24","span":{"begin":126,"end":135},"obj":"Body_part"},{"id":"T25","span":{"begin":155,"end":158},"obj":"Body_part"},{"id":"T26","span":{"begin":171,"end":180},"obj":"Body_part"},{"id":"T27","span":{"begin":253,"end":266},"obj":"Body_part"}],"attributes":[{"id":"A24","pred":"fma_id","subj":"T24","obj":"http://purl.org/sig/ont/fma/fma62852"},{"id":"A25","pred":"fma_id","subj":"T25","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A26","pred":"fma_id","subj":"T26","obj":"http://purl.org/sig/ont/fma/fma62864"},{"id":"A27","pred":"fma_id","subj":"T27","obj":"http://purl.org/sig/ont/fma/fma9825"}],"text":"tion syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by low expression of the human leukocyte antigen D related (HLA-DR) on CD14 monocytes (Lukaszewicz et al., 2009), and an intermediate functional state of the immune system lacking obvious dysregulation. We investigated whether this classification might apply to patien"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T2","span":{"begin":253,"end":266},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"tion syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by low expression of the human leukocyte antigen D related (HLA-DR) on CD14 monocytes (Lukaszewicz et al., 2009), and an intermediate functional state of the immune system lacking obvious dysregulation. We investigated whether this classification might apply to patien"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T46","span":{"begin":15,"end":18},"obj":"Disease"}],"attributes":[{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"}],"text":"tion syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by low expression of the human leukocyte antigen D related (HLA-DR) on CD14 monocytes (Lukaszewicz et al., 2009), and an intermediate functional state of the immune system lacking obvious dysregulation. We investigated whether this classification might apply to patien"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T31","span":{"begin":120,"end":125},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T32","span":{"begin":171,"end":180},"obj":"http://purl.obolibrary.org/obo/CL_0000576"},{"id":"T33","span":{"begin":253,"end":266},"obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"tion syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by low expression of the human leukocyte antigen D related (HLA-DR) on CD14 monocytes (Lukaszewicz et al., 2009), and an intermediate functional state of the immune system lacking obvious dysregulation. We investigated whether this classification might apply to patien"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T20","span":{"begin":136,"end":143},"obj":"Chemical"},{"id":"T21","span":{"begin":159,"end":161},"obj":"Chemical"}],"attributes":[{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A21","pred":"chebi_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"}],"text":"tion syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by low expression of the human leukocyte antigen D related (HLA-DR) on CD14 monocytes (Lukaszewicz et al., 2009), and an intermediate functional state of the immune system lacking obvious dysregulation. We investigated whether this classification might apply to patien"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T23","span":{"begin":50,"end":56},"obj":"Phenotype"}],"attributes":[{"id":"A23","pred":"hp_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/HP_0100806"}],"text":"tion syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by low expression of the human leukocyte antigen D related (HLA-DR) on CD14 monocytes (Lukaszewicz et al., 2009), and an intermediate functional state of the immune system lacking obvious dysregulation. We investigated whether this classification might apply to patien"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T105","span":{"begin":102,"end":112},"obj":"GO:0010467"},{"id":"T106","span":{"begin":120,"end":125},"obj":"SP_6;NCBITaxon:9606"},{"id":"T107","span":{"begin":126,"end":135},"obj":"CL:0000738"},{"id":"T108","span":{"begin":136,"end":143},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T109","span":{"begin":155,"end":158},"obj":"PR:000029150"},{"id":"T110","span":{"begin":166,"end":170},"obj":"PR:000001889"},{"id":"T111","span":{"begin":171,"end":180},"obj":"CL:0000576"},{"id":"T112","span":{"begin":253,"end":266},"obj":"UBERON:0002405"},{"id":"T113","span":{"begin":283,"end":296},"obj":"GO:0065007"}],"text":"tion syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by low expression of the human leukocyte antigen D related (HLA-DR) on CD14 monocytes (Lukaszewicz et al., 2009), and an intermediate functional state of the immune system lacking obvious dysregulation. We investigated whether this classification might apply to patien"}

{"project":"2_test","denotations":[{"id":"32320677-28918754-19656930","span":{"begin":43,"end":47},"obj":"28918754"},{"id":"32320677-19707128-19656931","span":{"begin":202,"end":206},"obj":"19707128"}],"text":"tion syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by low expression of the human leukocyte antigen D related (HLA-DR) on CD14 monocytes (Lukaszewicz et al., 2009), and an intermediate functional state of the immune system lacking obvious dysregulation. We investigated whether this classification might apply to patien"}

{"project":"LitCovid-PubTator","denotations":[{"id":"184","span":{"begin":166,"end":170},"obj":"Gene"},{"id":"195","span":{"begin":120,"end":125},"obj":"Species"},{"id":"199","span":{"begin":50,"end":80},"obj":"Disease"}],"attributes":[{"id":"A184","pred":"tao:has_database_id","subj":"184","obj":"Gene:929"},{"id":"A195","pred":"tao:has_database_id","subj":"195","obj":"Tax:9606"},{"id":"A199","pred":"tao:has_database_id","subj":"199","obj":"MESH:D018805"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tion syndrome (MAS) (Kyriazopoulou et al., 2017), sepsis-induced immunoparalysis characterized by low expression of the human leukocyte antigen D related (HLA-DR) on CD14 monocytes (Lukaszewicz et al., 2009), and an intermediate functional state of the immune system lacking obvious dysregulation. We investigated whether this classification might apply to patien"}